Prawo i regulacje · 13/05/2005

DEA Proposes to Classify Pregabalin as Schedule V Controlled Substance

The Drug Enforcement Administration (DEA) is proposing to move pregabalin, a medication used to treat epilepsy and chronic pain, into Schedule V of the Controlled Substances Act (CSA), which would subject its manufacturers and distributors to stricter regulations and penalties, following a recommendation from the Department of Health and Human Services (DHHS) and an evaluation of relevant data by the DEA.